Skip to main content
. 2014 Apr 14;9:51. doi: 10.1186/1750-1172-9-51

Figure 2.

Figure 2

Enzyme replacement therapy against standard medical therapy after Monte Carlo simulation of transition probabilities. (A) Scatterplot of undiscounted incremental medical costs and QALYs (B) corresponding cost-effectiveness acceptability curve.